Ido Kaminsky

Prior to joining TIAP, Ido Kaminsky served as the Director of Business Analysis at FutuRx, a biotech incubator jointly established by J&J (JJDC), Takeda Ventures, and Orbimed Israel. There, he conducted scouting, deal flow, scientific and business analysis, and transactional activities. Ido was responsible for expanding FutuRx’s network with research centers and tech-transfer offices, conducting technology evaluation, and licensing IP as part of venture formation processes. In his time with FutuRx he took part in the inception of over 10 biotechnology start-ups.Ido also spent several years with RM Global Partners, a boutique investment bank and consulting firm in the pharma, biotechnology, and medical-device space. There, he worked on corporate strategy and financing with clients across Israel, the US, and Korea, as well as the inception of a the RMGP Biopharma Investment Fund. Before that, Ido was an Analyst at the Frankel Group, a US-based strategic consulting firm focused on life-science.Ido holds a M.Sc. in biochemistry from the Weizmann Institute of Science, Israel.